1.Anti-thyroid drugs—first choice for Graves' disease
Chinese Journal of Practical Internal Medicine 2003;0(01):-
Graves' disease,the most common disorder of hyperthyroidism,is an autoimmune disease related with autoantibody (TRAb),with the specific mechanism remaining incompletely understood.The therapies for Graves disease include three conventional methods:anti-thyroid drugs,radioiodine and surgery.Only treatment with anti-thyroid drugs is aimed at the immune factor;they can eliminate TRAb and lead to recovery ultimately.Literatures have drumed in that treatment with anti-thyroid drugs was a basic therapy for Graves' diseases,and they were the first choice to cure hyperthyroidism all over the world (except for the U.S.A).The drugs do not destroy the structure of thyroid follicle,and are safe and efficient;moreover,their effect is reversible and therefore do not cause permanent damage to the thyroid.Anti-thyroid drugs not only can be used alone,it also can be used before radioiodine or surgery.ATA chairman professor Cooper(NEJM,2005) propounded a therapy path for Graves' disease,which is helpful for clinical practice.
2.Analysis of Cause-related Marketing Strategy in Pharmaceutical Industry
China Pharmacy 2005;0(16):-
OBJECTIVE:To analyze the cause-related marketing strategy in pharmaceutical industry.METHODS:The theory of cause-related marketing was introduced and the cause-related marketing pattern was illustrated with examples.RESULTS&CONCLUSION:Pharmaceutical enterprises can achieve win-win effect in both economic returns and social effects by selecting suitable public welfare projects and applying cause-related marketing.
4.Immunoregulation of radix tanshinone on isolated-lung preservation
Chinese Journal of Primary Medicine and Pharmacy 2008;15(5):705-706
Objective The study is to investigate the effect of tanshinone on lung reperfusion injury. Methods 24 New-Zealand rabbits were randomly divided into two groups. In one group, the lungs were perfused and preserved with LPD solution, the other with LPD+ tanshinone solution. The isolated lungs were preserved for 18 hours and then reperfused with rewarming whole blood. After reperfusing 30 minutes the lung samples were examined by pathology, wet/dry weight and measure of NO, SOD and MDA. Results In two groups, the reperfusion injury lungs were fresh, but had partial congestion, edema and ecchymoma under naked eye, under light microscopy the structures of the pulmonary vesiculars, branchia and capillaries were complete, but the epithelial cells of the vesicles and capillaries in the LPD group were more swelling and hypertrophy than that in LPD+ tanshinone group. The wet/dry weight ratio was significantly lower in LPD+ tanshinone group than in the LPD group. NO [(2.16±2.15)μmol/g] and SOD [(37.03±18.01NU/mg] were higher in the LPD+ tanshinone group than in the LPD group [(0.68±0.33) μmol/g, (17.63±11.04)NU/mg] (all P<0.05), MDA was lower in the LPD+ tanshinone group [(0.47±0.20)μmol/mg] than in the LPD group [(0.86±0.44)μmol/mg] (P<0.05). Conclusions Tanshinone can dean oxygen free radical and is of stronger antioxidation, results in alleriating of lung reperfusing injury. Tanshinone has positive effect on preservative quality of the reperfusion injury lung.
5.Clinical Evaluation of the Level of Serum CA125 for Hepatic Functional Lesion in Patients with Cirrhosis
Journal of Medical Research 2006;0(07):-
Objective To investigate the clinic significance of serum carbohydrate antigen ( CA)125 for cirrhosis. Methods 88 patients with type B posthepatitic cirrhosis (male 46,female 24,average age 45?24 years) were divided into three group (A stage35,B stage 28,C stage 25) according to Child-pugh integration. 36 healthy persons as normal controls were studied(male 20,female 16,average age 42?22 years). Serum CA125 was measured by ELISA. We investigated the alteration of serum CA125 with hepatic functional classification. Results The levels of serum CA125 in cirrhosis patients were markedly higher than those in control subjects(P
6.Endoscopic diagnosis and treatment of Barrett's esophagus
Chinese Journal of Practical Internal Medicine 2001;0(09):-
Barrett's esophagus is known the only precancerous lesions of esophageal adenocarcinoma.Besides conventional endoscopy and pathologic biopsy,drugs and surgical treatment of the Barrett's esophagus,in recent years,some new endoscopic diagnosis and treatment technology were obtained.The progress of endoscopic diagnosis and therapy technique in Barrett's esophagus are reviewed in this paper.
7.Discussion on Customer Value Management in Pharmaceutical Enterprises
China Pharmacy 1991;0(04):-
OBJECTIVE:To introduce a customer - centric management strategy, i.e, customer value management (CVM). METHODS: Theory of customer value management and customer value analysis were applied in combination with the actual situation of pharmaceutical enterprises.RESULTS & CONCLUSION:Pharmaceutical enterprises should pay great attention to CVM strategy to continuously fulfill customer demands.
8.CIK cells and their application in the tumor treatment
Journal of International Oncology 2015;42(2):130-133
Cytokine-induced killer (CIK) cells play important roles in the treatment of solid tumors.In particular,they have broad application prospects for the patients with recurrence or metastasis.Although recently CIK treatment strategy has achieved encouraging results in preclinical studies,there are still some difficulties in the clinical applications.Some key issues remain to be resolved,such as how to ensure that the antitumor immune effector can be a lot of amplified and can stay longer in the body,how to selectively kill tumor cells,and how to ensure the security of application.
9.Effect of Hongjingtian injection adjuvant therapy on blood glucose, blood lipid and clinical efficacy in patients with acute cerebral infarction
Chinese Journal of Biochemical Pharmaceutics 2015;(11):158-160
Objective To investigate effect of Hongjingtian injection adjuvant therapy on blood glucose, blood lipid and clinical efficacy in patients with acute cerebral infarction.Methods 40 cases of acute cerebral infarction in our hospital were randomly divided into control group and experimental group.20 cases in control group were treated with routine treatment, 20 cases in experimental group were treated on the basis of control group by Hongjingtian injection.Fasting blood glucose, blood lipids and clinical efficacy were compared post-treatment.Results Compared with pre-treatment, the level of LDL-C and TC in control group was lower(P <0.05), the levels of FBG, TC, TG and LDL-C in experimental group were lower (P <0.05), and the HDL-C level was higher (P<0.05).Compared with control group, the levels of LDL-C, TG, TC and FBG in experimental group were lower (P<0.05), and the HDL-C level was higher (P<0.05).The total effective rate of experimental group (95.00%) was higher than control group (65.00%)(P<0.05).Conclusion Hongjingtian injection can decrease the level of fasting blood glucose in patients with acute cerebral infarction and decrease serum TG, TC, LDL-C level, increase the level of HDL-C, improve the clinical efficacy, and have a guiding significance for clinical.
10.Analysis of Clinical and Pathological Characteristics and Prognosis in 21 Children with Primary Focal Segmental Glomerulosclerosis
Journal of Applied Clinical Pediatrics 1992;0(05):-
0.05).Two cases were lost to follow up,19 out of 21 cases were followed up.The follow-up duration was from 4 to 51 months[mean follow-up duration was(22.84?12.13) months].At last follow-up,10 cases(53%) had complete remission,4 cases(21%) had significant remission,4 cases(21%) had partial remission and 1 case(5%) had no remission.Tubulointerstitial lesions were related with prognosis(P1).Conclusions 1.The predominant clinical manifestation of primary FSGS is nephrotic syndrome in children.The not otherwise specified variant is the commonest pathological variant in primary FSGS.There is no relationship between patholo-gical types and clinical manifestations of FSGS.2.Most of the children with primary FSGS have a good short-term prognosis,but their long-term prognosis must be followed up.3.Tubulointerstitial lesions are risk factors for prognosis.